Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Product Development

An understudied dementia soon to get a pair of Phase II readouts

CervoMed and Cognition Therapeutics testing different therapeutic hypotheses in dementia with Lewy bodies

November 19, 2024 2:23 AM UTC

Ask a dementia expert what the most common neurodegenerative disease is that people have never heard of and the answer will be dementia with Lewy bodies. Affecting an estimated 1.4 million people in the U.S. alone, the condition ranks second only to Alzheimer’s among dementias, and third, after Alzheimer’s and Parkinson’s, among neurodegenerative diseases.

Despite its prevalence, dementia with Lewy bodies (DLB) remains underdiagnosed and less understood than other neurodegenerative disorders. No drugs have been approved to treat the condition. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article